Nathan Hillson

Dr. Nathan Hillson

Biological Systems & Engineering, Lawrence Berkeley National Laboratory, Berkeley, California, USA
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2011 in ACS Synthetic Biology
Verified
Journal Article
Closed access
Nathan HillsonNathan Hillson
Nathan Hillson
RRRafael D. Rosengarten
Rafael D. Rosengarten
JKJay D. Keasling
Jay D. Keasling

18 June 2018 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
SPSebastian Palluk
Sebastian Palluk
DADaniel H Arlow
Daniel H Arlow
TRTristan de Rond
Tristan de Rond
SBSebastian Barthel
Sebastian Barthel
JKJustine S Kang
Justine S Kang
JKJay D. Keasling
Jay D. Keasling
Oligonucleotides are almost exclusively synthesized using the nucleoside phosphoramidite method, even though it is limited to the direct synthesis of ∼ 200 mers and produces hazardous waste. Here, we describe an oligonucleotide synthesis strategy that uses the template-independent polymerase terminal deoxynucleotidyl transferase (TdT). Each TdT molecule is conjugated to a single deoxyribonucleoside triphosphate (dNTP) molecule that it can incorporate into a primer. After incorporation of the tethered dNTP, the 3′ end of the primer remains covalently bound to TdT and is inaccessible to other TdT–dNTP molecules. Cleaving the linkage between TdT and the incorporated nucleotide releases the primer and allows subsequent extension. We demonstrate that TdT–dNTP conjugates can quantitatively extend a primer by a single nucleotide in 10–20 s, and that the scheme can be iterated to write a defined sequence. This approach may form the basis of an enzymatic oligonucleotide synthesizer.

9 May 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
Nathan HillsonNathan Hillson
Nathan Hillson
MCMark Caddick
Mark Caddick
YCYizhi Cai
Yizhi Cai
JLJosé Antonio Carrasco Lopez
José Antonio Carrasco Lopez
MCMatthew Wook Chang
Matthew Wook Chang
PFPaul S. Freemont
Paul S. Freemont
Biofoundries provide an integrated infrastructure to enable the rapid design, construction, and testing of genetically reprogrammed organisms for biotechnology applications and research. Many biofoundries are being built and a Global Biofoundry Alliance has recently been established to coordinate activities worldwide.

9 May 2019 in ACS Synthetic Biology
Verified
Journal Article
Open access
POPaul Opgenorth
Paul Opgenorth
ZCZak Costello
Zak Costello
TOTakuya Okada
Takuya Okada
GGGarima Goyal
Garima Goyal
YCYan Chen
Yan Chen
HBHarry R. Beller
Harry R. Beller
The Design–Build–Test–Learn (DBTL) cycle, facilitated by exponentially improving capabilities in synthetic biology, is an increasingly adopted metabolic engineering framework that represents a more systematic and efficient approach to strain development than historical efforts in biofuels and bio-based products. Here, we report on implementation of two DBTL cycles to optimize 1-dodecanol production from glucose using 60 engineered Escherichia coli MG1655 strains. The first DBTL cycle employed a simple strategy to learn efficiently from a relatively small number of strains (36), wherein only the choice of ribosome-binding sites and an acyl-ACP/acyl-CoA reductase were modulated in a single pathway operon including genes encoding a thioesterase (UcFatB1), an acyl-ACP/acyl-CoA reductase (Maqu_2507, Maqu_2220, or Acr1), and an acyl-CoA synthetase (FadD). Measured variables included concentrations of dodecanol and all proteins in the engineered pathway. We used the data produced in the first DBTL cycle to train several machine-learning algorithms and to suggest protein profiles for the second DBTL cycle that would increase production. These strategies resulted in a 21% increase in dodecanol titer in Cycle 2 (up to 0.83 g/L, which is more than 6-fold greater than previously reported batch values for minimal medium). Beyond specific lessons learned about optimizing dodecanol titer in E. coli, this study had findings of broader relevance across synthetic biology applications, such as the importance of sequencing checks on plasmids in production strains as well as in cloning strains, and the critical need for more accurate protein expression predictive tools.

13 November 2013 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
CBChanghao Bi
Changhao Bi
PSPeter Su
Peter Su
JMJana Müller
Jana Müller
YYYi-Chun Yeh
Yi-Chun Yeh
SCSwapnil R Chhabra
Swapnil R Chhabra
Nathan HillsonNathan Hillson
Nathan Hillson
The chemoautotrophic bacterium Ralstonia eutropha can utilize H2/CO2 for growth under aerobic conditions. While this microbial host has great potential to be engineered to produce desired compounds (beyond polyhydroxybutyrate) directly from CO2, little work has been done to develop genetic part libraries to enable such endeavors.

1 December 2012 in Journal of Biological Engineering
Verified
Journal Article
Open access
PDF file
JCJoanna Chen
Joanna Chen
DDDouglas Densmore
Douglas Densmore
THTimothy S Ham
Timothy S Ham
JKJay D. Keasling
Jay D. Keasling
Nathan HillsonNathan Hillson
Nathan Hillson
Background: Biological Computer Aided Design (bioCAD) assists the de novo design and selection of existing genetic components to achieve a desired biological activity, as part of an integrated design-build-test cycle. To meet the emerging needs of Synthetic Biology, bioCAD tools must address the increasing prevalence of combinatorial library design, design rule specification, and scar-less multi-part DNA assembly. Results: We report the development and deployment of web-based bioCAD software, DeviceEditor, which provides a graphical design environment that mimics the intuitive visual whiteboard design process practiced in biological laboratories. The key innovations of DeviceEditor include visual combinatorial library design, direct integration with scar-less multi-part DNA assembly design automation, and a graphical user interface for the creation and modification of design specification rules. We demonstrate how biological designs are rendered on the DeviceEditor canvas, and we present effective visualizations of genetic component ordering and combinatorial variations within complex designs. Conclusions: DeviceEditor liberates researchers from DNA base-pair manipulation, and enables users to create successful prototypes using standardized, functional, and visual abstractions. Open and documented software interfaces support further integration of DeviceEditor with other bioCAD tools and software platforms. DeviceEditor saves researcher time and institutional resources through correct-by-construction design, the automation of tedious tasks, design reuse, and the minimization of DNA assembly costs.